Male fertility plays a critical role in IVF and ART success. Dr. Eric Lacy explains science-backed steps men can take — nutrition, exercise, supplements, reducing toxins, and stress — plus the ideal pre-treatment timeline to improve sperm health and treatment outcomes.

Biotechnology is redefining fertility care—from the lab to the living room. In this thought-leadership article, Rod Duell, CEO of Aqua Fem, examines how emerging innovations in reproductive biology are bridging the gap between cutting-edge science and accessible care. Key topics covered: Advances in male and female fertility biotech The intersection of biotechnology and ART Biotech’s role in cost reduction and accessibility Advocacy’s role in translating science into patient

Male infertility accounts for nearly half of all infertility cases, yet stigma still silences millions. Eric Lacy, PhD, Chief Scientific Officer of Aqua Fem, shares how cultural and clinical shifts can help normalize male fertility discussions and improve outcomes.

In this article, Rod Duell, CEO of Aqua Fem, explores how founders and executives can preserve integrity and purpose while scaling, and why mission alignment is becoming one of the strongest competitive advantages in biotech today.

Discover how modern at-home male fertility testing is evolving—from simple smartphone kits to comprehensive lab-analyzed services by companies like Sapyen, Fellow, and Legacy. Expert insight from Dr. Eric Lacy on accuracy, awareness, and early detection.

Biotech innovation faces skepticism before adoption. Learn five practical strategies to turn skeptics into advocates through data transparency, early champion engagement, and adaptive leadership.

Learn how environmental risks like endocrine disruptors, heat exposure, air pollution, and workplace hazards impact sperm health — plus practical steps to protect male fertility.

Discover how biotech startups can accelerate growth through strategic partnerships in R&D, clinical trials, commercialization, and distribution. Learn best practices, pitfalls to avoid, and case studies from the field.

Learn how sperm DNA fragmentation impacts fertility, ART success rates, and miscarriage risk. Discover testing options, interventions, and why DNA integrity should matter in reproductive care.

Discover how biotech companies can build defensible value through proprietary data, trade secrets, brand equity, scientific credibility, and strategic partnerships—not just patents.

A standard semen analysis measures concentration, motility, and morphology—but these basic numbers often miss hidden sperm issues. Discover how advanced tests like CASA, vitality staining, and DNA fragmentation analysis provide deeper insights for fertility care.

Learn how to simplify complex biotech concepts without losing accuracy. Discover strategies for science communication that resonate with investors, regulators, partners, and the public — with practical storytelling, analogies, and visuals.

Sperm health is more than fertility. Learn why male fertility testing should be part of preventive healthcare and annual men’s checkups.

Discover how translational science bridges the gap between biotech innovation and real-world healthcare impact. Learn why usability, scalability, and equity are essential for bringing fertility treatment innovations—like Aqua Fem’s AF compound—successfully from lab to life.

Explore new sperm selection methods—microfluidics, MACS, and more—reshaping ART outcomes and advancing male fertility science.

Learn how biotech startups can secure the right funding at the right time while protecting scientific integrity and mission. Aqua Fem shares insights on investor alignment and strategic capital.

Everyday habits—from diet and sleep to stress and toxins—directly affect sperm health. Learn how lifestyle changes can improve male fertility in just months.

Discover why early FDA regulatory planning is essential for biotech startups. Learn about 510(k), De Novo, PMA pathways, and how smart engagement accelerates product development and market success.

A semen analysis measures key markers of male fertility—volume, count, motility, morphology, and more. Learn what the numbers mean and why they matter.

Learn how reverse-engineering biotech innovation—from patient needs to regulatory milestones—can accelerate funding, market success, and real-world impact. Insights from Aqua Fem.